This might be a population of patients that would benefit from Generex Biotechnolgy's "Complete Vaccine" that should be about to start trials. Unfortunately that means they are a way off from bringing it to market.

BTW, I emaled Dr Pourhassan, GNBT's recent trademark action about the vaccine as a potential concept for CYDY. Leronlimab has so many applications it would be fitting to have a marketing tag.